ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $144,000 | -8.3% | 11,600 | -53.8% | 0.00% | -25.0% |
| Q4 2015 | $157,000 | +6.8% | 25,100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $147,000 | -75.2% | 25,100 | -70.9% | 0.00% | -60.0% |
| Q4 2014 | $593,000 | +34.2% | 86,284 | +5.5% | 0.01% | +25.0% |
| Q3 2014 | $442,000 | -18.3% | 81,784 | -3.8% | 0.01% | -20.0% |
| Q2 2014 | $541,000 | +93.9% | 84,984 | +145.7% | 0.01% | +100.0% |
| Q1 2014 | $279,000 | -26.6% | 34,584 | -37.9% | 0.01% | 0.0% |
| Q4 2013 | $380,000 | – | 55,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
| DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
| Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
| BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
| SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
| OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
| Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
| Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |